Get ready for the ultimate showdown in this year’s KOL KNOCKOUT™: Oculoplastics Edition | Eyeing Up the Best in TED Management.
This action-packed CME symposium on thyroid eye disease will have a few returning faces: Program Chair Andrew R. Harrison, MD, will moderate the action and the 2024 Champion, Wendy W. Lee, MD, also returns to defend her title. Dr. Lee faces off against fellow contenders Roger A. Dailey, MD, FACS, and Robert C. Kersten, MD, in a fierce clash of strategies over the toughest clinical cases.
Join us online or in person for this thrilling conclusion packed with expert insights, fierce debate, and can't-miss clinical pearls!
This symposium is not part of the ASOPRS 2025 Fall Scientific Symposium.
advertisement
KOL KO™: Oculoplastics Edition | Eyeing Up the Best in TED Management
This action-packed CME symposium brings together experts in thyroid eye disease to battle over management strategies for the toughest clinical cases.
Live
Meeting
1.00 available credits
Information
October 17, 2025
11:50 AM - 12:50 PM ET
Rosen Shingle Creek
9939 Universal Blvd, Room: Sebastian L1&2, Orlando, Florida, United States
Share
Share
Share
Share this program on:
Details
Presenters
Overview
Target Audience
This certified continuing medical education activity is designed for oculoplastic surgeons, neuro-ophthalmologists, and comprehensive ophthalmologists.
Grantor Statement
This activity is supported by an unrestricted educational grant from Amgen.
Learning Objectives
Upon completion of this activity, learners should be better able to:
- Interpret clinical features and patient-reported impact of TED to determine disease severity and guide treatment decisions
- Choose the diagnostic evaluations needed to clarify TED diagnosis
- Weigh different treatment modalities for TED and select the most effective option based on disease severity and patient-specific factors
- Implement evidence-based strategies to monitor, mitigate, and manage adverse events associated with biologic therapies for TED
Accreditation and Credit Designation Statements
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Disclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, it is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.
The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.
Andrew R. Harrison, MD,has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen, Argenx, Viridian. Grant/Research Support: Viridian. Speaker’s Bureau: Amgen.
Roger A. Dailey, MD, FACS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen, Viridian. Grant/Research Support: Lester T. Jones Endowed Chair, Oculofacial Plastic Surgery. Advisory Board: SKLIP Inc., Natures Tears.
Robert C. Kersten, MD, has no relevant relationships to disclose.
Wendy W. Lee, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Allergan, Galderma, Revance, Evolus, RoC, Tarsus, Viatris, Viridian, Amgen, Acelyrin, Ethyreal, Santen
The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Amgen.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.Faculty
Andrew R. Harrison, MD
Professor and Vice Chair
Poland-Finke Endowed Chair
Director of Oculofacial Plastic and Orbital Surgery
Departments of Ophthalmology and Otolaryngology
University of Minnesota
Minneapolis, MN
Roger A. Dailey, MD, FACS
Oculofacial Plastic & Reconstructive Surgery Division
Director, Casey Aesthetic Facial Surgery Center
Casey Eye Institute
Oregon Health & Science University
Portland, OR
Robert C. Kersten, MD
John A. Moran Eye Center
University of Utah
Salt Lake City, UT
Wendy W. Lee, MD
Professor of Clinical Ophthalmology and Dermatology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, FLADA Statement
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Andrea Mathis prior to the live event at amathis@glc.healthcare.
Details
Presenters
Overview
Get ready for the ultimate showdown in this year’s KOL KNOCKOUT™: Oculoplastics Edition | Eyeing Up the Best in TED Management.
This action-packed CME symposium on thyroid eye disease will have a few returning faces: Program Chair Andrew R. Harrison, MD, will moderate the action and the 2024 Champion, Wendy W. Lee, MD, also returns to defend her title. Dr. Lee faces off against fellow contenders Roger A. Dailey, MD, FACS, and Robert C. Kersten, MD, in a fierce clash of strategies over the toughest clinical cases.
Join us online or in person for this thrilling conclusion packed with expert insights, fierce debate, and can't-miss clinical pearls!
This symposium is not part of the ASOPRS 2025 Fall Scientific Symposium.Target Audience
This certified continuing medical education activity is designed for oculoplastic surgeons, neuro-ophthalmologists, and comprehensive ophthalmologists.
Grantor Statement
This activity is supported by an unrestricted educational grant from Amgen.
Learning Objectives
Upon completion of this activity, learners should be better able to:
- Interpret clinical features and patient-reported impact of TED to determine disease severity and guide treatment decisions
- Choose the diagnostic evaluations needed to clarify TED diagnosis
- Weigh different treatment modalities for TED and select the most effective option based on disease severity and patient-specific factors
- Implement evidence-based strategies to monitor, mitigate, and manage adverse events associated with biologic therapies for TED
Accreditation and Credit Designation Statements
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Disclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, it is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.
The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.
Andrew R. Harrison, MD,has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen, Argenx, Viridian. Grant/Research Support: Viridian. Speaker’s Bureau: Amgen.
Roger A. Dailey, MD, FACS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen, Viridian. Grant/Research Support: Lester T. Jones Endowed Chair, Oculofacial Plastic Surgery. Advisory Board: SKLIP Inc., Natures Tears.
Robert C. Kersten, MD, has no relevant relationships to disclose.
Wendy W. Lee, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Allergan, Galderma, Revance, Evolus, RoC, Tarsus, Viatris, Viridian, Amgen, Acelyrin, Ethyreal, Santen
The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Amgen.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.Faculty
Andrew R. Harrison, MD
Professor and Vice Chair
Poland-Finke Endowed Chair
Director of Oculofacial Plastic and Orbital Surgery
Departments of Ophthalmology and Otolaryngology
University of Minnesota
Minneapolis, MN
Roger A. Dailey, MD, FACS
Oculofacial Plastic & Reconstructive Surgery Division
Director, Casey Aesthetic Facial Surgery Center
Casey Eye Institute
Oregon Health & Science University
Portland, OR
Robert C. Kersten, MD
John A. Moran Eye Center
University of Utah
Salt Lake City, UT
Wendy W. Lee, MD
Professor of Clinical Ophthalmology and Dermatology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, FLADA Statement
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Andrea Mathis prior to the live event at amathis@glc.healthcare.
Recommended
KOL KO™: Oculoplastics Edition | Eyeing Up the Best in TED Management
KOL KO™: Oculoplastics Edition | Eyeing Up the Best in TED Management
CME/CE Live BroadcastKOL KO™: Oculoplastics Edition | Eyeing Up the Best in TED Management
October 17, 2025
11:50 AM - 12:50 PM ET
1.00 credit Learn more